IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
iRadimed Corporation (IRMD)
Last iradimed corporation earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
iradimed.com/en-us/investors/investor-contact
Company Research
Source: GlobeNewswire
Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER SPRINGS, Fla., Nov. 03, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2022. The Company is a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices and the only known provider of a non-magnetic intravenous ("IV") infusion pump system and non-magnetic patient vital signs monitoring systems designed for use during MRI procedures. "This quarter's results demonstrate Iradimed's continued ability to execute revenue growth and profitability. I am very pleased to point out that our impressive year-over-year quarterly revenue growth of 23% resulted in a 35% growth rate in quarterly diluted earnings per share compared to a year earlier. In a
Show less
Read more
Impact Snapshot
Event Time:
IRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRMD alerts
High impacting iRadimed Corporation news events
Weekly update
A roundup of the hottest topics
IRMD
News
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Capital.MarketBeat
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $65.00 price target on the stock.MarketBeat
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Singular Research.MarketBeat
- IRADIMED CORPORATION's (NASDAQ:IRMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference [Yahoo! Finance]Yahoo! Finance
IRMD
Earnings
- 2/8/24 - Beat
IRMD
Sec Filings
- 4/3/24 - Form S-3
- 3/1/24 - Form 10-K
- 2/13/24 - Form SC
- IRMD's page on the SEC website